Silence Therapeutics plc logo
Silence Therapeutics plc SLN
$ 10.14 0.78%
report update icon

Quarterly report 2026-Q2
added 08-10-2026

Silence Therapeutics plc Market Cap | SLN

As of October 06, 2026 Silence Therapeutics plc has a market cap of $ 1.44 B


Capitalization is the market value of a company whose shares are traded on the stock exchange. It is calculated by multiplying the market price of a share by the total number of the company's shares. Capitalization indicates volatility, risk, and growth potential. This metric is often used for a quick assessment of a company’s investment profile.[1]

Capitalization is an important indicator for investors and analysts, as it helps determine the size and significance of a company in the stock market. Companies with large capitalization are considered more stable and reliable, as they have more resources and financial power to grow and survive in the market.

This metric can be divided into several categories: small (from 300 million to 2 billion dollars), medium (from 2 to 10 billion dollars), and large (over 10 billion dollars). Companies with different levels of capitalization have their own characteristics and risks, so investors usually take this indicator into account when making investment decisions.

Capitalization can also change over time depending on the share price and the number of shares in circulation. Therefore, it is a dynamic indicator that requires constant monitoring and analysis to make well-informed investment decisions.

Annual Market Cap Silence Therapeutics plc

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
812 M 2.86 B 2.44 B 675 M 1.63 B 632 M - - - - 52.9 M - - - -

All numbers in GBP currency

Indicator range from annual reports

Maximum Minimum Average
2.86 B 52.9 M 1.3 B

References

  1. Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.

Market Cap of other stocks in the Biotechnology industry

Issuer Market Cap Price % 24h Market Cap Country
Theravance Biopharma Theravance Biopharma
TBPH
742 M $ 17.03 0.03 % $ 857 M cayman-islandsCayman-islands
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
28.9 M - -1.52 % $ 24.7 M usaUSA
Forte Biosciences Forte Biosciences
FBRX
335 M $ 76.99 0.03 % $ 997 M usaUSA
Aptose Biosciences Aptose Biosciences
APTO
2.32 M - -45.71 % $ 1.2 M canadaCanada
Cleveland BioLabs, Inc. Cleveland BioLabs, Inc.
CBLI
56.9 M - -7.31 % $ 49 M usaUSA
Five Prime Therapeutics, Inc. Five Prime Therapeutics, Inc.
FPRX
616 M - - $ 1.77 B usaUSA
Biofrontera AG Biofrontera AG
BFRA
220 M - -8.24 % $ 105 M germanyGermany
Catabasis Pharmaceuticals, Inc. Catabasis Pharmaceuticals, Inc.
CATB
80.6 M - -6.97 % $ 657 M usaUSA
China Biologic Products Holdings, Inc. China Biologic Products Holdings, Inc.
CBPO
4.56 B - 1.68 % $ 4.65 B chinaChina
Flexion Therapeutics, Inc. Flexion Therapeutics, Inc.
FLXN
521 M - - $ 459 M usaUSA
Heat Biologics, Inc. Heat Biologics, Inc.
HTBX
32.8 M - -5.76 % $ 99.8 M usaUSA
Kindred Biosciences, Inc. Kindred Biosciences, Inc.
KIN
196 M - 0.11 % $ 419 M usaUSA
Shineco, Inc. Shineco, Inc.
TYHT
13.2 M - -3.90 % $ 97.2 M chinaChina
Millendo Therapeutics, Inc. Millendo Therapeutics, Inc.
MLND
2.5 M - -5.36 % $ 20.2 M usaUSA
Intec Pharma Ltd Intec Pharma Ltd
NTEC
16.1 M - -12.45 % $ 17.7 M israelIsrael
Progenity, Inc. Progenity, Inc.
PROG
339 M - -3.47 % $ 164 M usaUSA
Strongbridge Biopharma plc Strongbridge Biopharma plc
SBBP
151 M - 1.52 % $ 136 M usaUSA
Seneca Biopharma, Inc. Seneca Biopharma, Inc.
SNCA
538 K - -1.19 % $ 28.7 M usaUSA
Celsion Corporation Celsion Corporation
CLSN
2.01 M - -6.63 % $ 13.9 M usaUSA
I-Mab I-Mab
IMAB
127 M - - $ 866 M chinaChina
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
33.6 B - - $ 40.3 B usaUSA
Genfit SA Genfit SA
GNFT
168 B - 2.54 % $ 160 B franceFrance
Biophytis SA Biophytis SA
BPTS
179 M - -13.47 % $ 169 M franceFrance
CureVac N.V. CureVac N.V.
CVAC
3.53 B - - $ 867 M germanyGermany
BiondVax Pharmaceuticals Ltd. BiondVax Pharmaceuticals Ltd.
BVXV
740 M - 0.74 % $ 768 M israelIsrael
Abcam plc Abcam plc
ABCM
4.94 B - - $ 4.9 B britainBritain
Midatech Pharma plc Midatech Pharma plc
MTP
1.44 B - -18.52 % $ 27.3 M britainBritain
MorphoSys AG MorphoSys AG
MOR
624 M - 2.43 % $ 254 M germanyGermany
Affimed N.V. Affimed N.V.
AFMD
527 M - -34.95 % $ 21.5 M germanyGermany
AnPac Bio-Medical Science Co., Ltd. AnPac Bio-Medical Science Co., Ltd.
ANPC
167 M - -1.58 % $ 28.1 M chinaChina
Celyad Oncology SA Celyad Oncology SA
CYAD
10.6 M - - $ 12.5 M belgiumBelgium
Gracell Biotechnologies Gracell Biotechnologies
GRCL
1.99 B - - $ 3.37 B chinaChina
Galapagos NV Galapagos NV
GLPG
1.91 B - - $ 1.83 B belgiumBelgium
Teligent, Inc. Teligent, Inc.
TLGT
5.03 M - -13.85 % $ 16.1 M usaUSA
Viela Bio, Inc. Viela Bio, Inc.
VIE
427 M - - $ 2.91 B usaUSA
Aphria Inc. Aphria Inc.
APHA
1.11 B - -0.45 % $ 4.87 B canadaCanada
Aerpio Pharmaceuticals, Inc. Aerpio Pharmaceuticals, Inc.
ARPO
63.6 M - -0.90 % $ 104 M usaUSA
Chiasma, Inc. Chiasma, Inc.
CHMA
207 M - -6.00 % $ 238 M usaUSA
Adamas Pharmaceuticals, Inc. Adamas Pharmaceuticals, Inc.
ADMS
164 M - - $ 376 M usaUSA
Cellect Biotechnology Ltd. Cellect Biotechnology Ltd.
APOP
485 M - 0.38 % $ 12.9 M israelIsrael
AzurRx BioPharma, Inc. AzurRx BioPharma, Inc.
AZRX
40.9 M - 2.07 % $ 34.4 M usaUSA
Cerecor Inc. Cerecor Inc.
CERC
230 M - -1.68 % $ 283 M usaUSA
Constellation Pharmaceuticals, Inc. Constellation Pharmaceuticals, Inc.
CNST
1.57 B - - $ 1.63 B usaUSA
Auris Medical Holding Ltd. Auris Medical Holding Ltd.
EARS
8.29 M - -1.77 % $ 39.2 M bermudaBermuda
Dicerna Pharmaceuticals, Inc. Dicerna Pharmaceuticals, Inc.
DRNA
1.67 B - 0.34 % $ 2.98 B usaUSA
ERYTECH Pharma S.A. ERYTECH Pharma S.A.
ERYP
24.2 M - 1.3 % $ 27.7 M franceFrance
GW Pharmaceuticals plc GW Pharmaceuticals plc
GWPH
4.79 B - - $ 6.81 B britainBritain
Kadmon Holdings, Inc. Kadmon Holdings, Inc.
KDMN
813 M - - $ 1.7 B usaUSA
Liminal BioSciences Liminal BioSciences
LMNL
2.65 M - - $ 256 M canadaCanada